Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Soloway

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Urology|March 1, 1995
Treatment with finasteride following radical prostatectomy for prostate cancerG Andriole, M Lieber, J Smith, et al.
The Journal of Urology|July 1, 1996
Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate?M Perrotti, R P Kaufman, T A Jennings, et al.
Urology|April 1, 1997
Assessment of endpoints for clinical trials for localized prostate cancerP Schellhammer, A Cockett, L Boccon-Gibod, et al.
Urology|May 1, 1995
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study GroupP Schellhammer, R Sharifi, N Block, et al.
Urology|January 1, 1996
Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study GroupP Schellhammer, R Sharifi, N Block, et al.
Progress in Clinical and Biological Research|January 1, 1986
Prognostic factors in superficial bladder cancerY Aso, L Anderson, M Soloway, et al.
The Journal of Urology|March 1, 1992
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary GroupT A Splinter, H I Scher, L Denis, et al.
Cancer|April 15, 1980
Chemotherapy programs of the National Prostatic Cancer Project (NPCP)J D Schmidt, W W Scott, R Gibbons, et al.
Urology|March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsW R Fair, M S Cookson, N Stroumbakis, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Urology|March 1, 1995
Treatment with finasteride following radical prostatectomy for prostate cancerG Andriole, M Lieber, J Smith, et al.
The Journal of Urology|July 1, 1996
Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate?M Perrotti, R P Kaufman, T A Jennings, et al.
Urology|April 1, 1997
Assessment of endpoints for clinical trials for localized prostate cancerP Schellhammer, A Cockett, L Boccon-Gibod, et al.
Urology|May 1, 1995
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study GroupP Schellhammer, R Sharifi, N Block, et al.
Urology|January 1, 1996
Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study GroupP Schellhammer, R Sharifi, N Block, et al.
Progress in Clinical and Biological Research|January 1, 1986
Prognostic factors in superficial bladder cancerY Aso, L Anderson, M Soloway, et al.
The Journal of Urology|March 1, 1992
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary GroupT A Splinter, H I Scher, L Denis, et al.
Cancer|April 15, 1980
Chemotherapy programs of the National Prostatic Cancer Project (NPCP)J D Schmidt, W W Scott, R Gibbons, et al.
Urology|March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsW R Fair, M S Cookson, N Stroumbakis, et al.
Pageof 4